Clinical and molecular characteristics of <i>RNF43</i> mutations as promising prognostic biomarkers in colorectal cancer.
Journal Information
Full Title: Ther Adv Med Oncol
Abbreviation: Ther Adv Med Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors declare that there is no conflict of interest."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported, in part, by the Guangdong Basic and Applied Basic Research Foundation (Grand number: 2023B1515020015); National Natural Science Foundation of China (Grant numbers: 82073302, 81930065, 82173128); the Fundamental Research Funds for the Central Universities, Sun Yat-sen University (Grand number: 22qntd4001); the CAMS Innovation Fund for Medical Sciences (CIFMS) (Grant number: 2019-I2M-5-036); Beijing Health Alliance Charitable Foundation (Grand number: BJHA-CRP-058). The funders played no role in designing the study, collecting, analyzing, or interpreting data, nor did they contribute to the writing of the manuscript."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025